🇺🇸 Ganoderma in United States

44 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 6 reports (13.64%)
  2. Malignant Neoplasm Progression — 5 reports (11.36%)
  3. Nausea — 5 reports (11.36%)
  4. Alanine Aminotransferase Increased — 4 reports (9.09%)
  5. Asthenia — 4 reports (9.09%)
  6. Blood Calcium Increased — 4 reports (9.09%)
  7. Blood Magnesium Increased — 4 reports (9.09%)
  8. Blood Phosphorus Increased — 4 reports (9.09%)
  9. Death — 4 reports (9.09%)
  10. Dizziness — 4 reports (9.09%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Ganoderma approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ganoderma in United States?

Xuanwu Hospital, Beijing is the originator. The local marketing authorisation holder may differ — check the official source linked above.